Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

For speculative investors, the start of each year is always a good time to revisit an initial public offering (IPO) calendar.

The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...

Novo Nordisk NVO shares have surged 18.8% in the past month. The stock price gain was primarily induced by the ...

Novo Nordisk's new chief executive, Mike Doustdar, has told the JPM Healthcare conference that the key to competing in the ...

A veteran FDA regulator who left last month said the firewall between agency political appointees and drug reviewers “has ...

Eli Lilly and Novo Nordisk make the world’s most popular weight loss drugs. These injectable products have generated ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.